Epizyme Inc. buy melinda
Start price
14.06.17
/
50%
€11.84
Target price
22.06.17
€16.24
Performance (%)
10.06%
End price
22.06.17
€13.03
Summary
This prediction ended on 22.06.17 with a price of €13.03. The prediction had a final performance of 10.06%. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Epizyme Inc. | - | - | - | - |
| iShares Core DAX® | 1,43 % | 1,58 % | 13,25 % | 61,14 % |
| iShares Nasdaq 100 | 1,89 % | -2,28 % | 2,99 % | 88,34 % |
| iShares Nikkei 225® | -1,62 % | 7,95 % | 27,69 % | 65,18 % |
| iShares S&P 500 | 1,92 % | -0,28 % | 2,99 % | 61,15 % |
Comments by melinda for this prediction
In the thread Epizyme Inc. diskutieren
Gesundheit | Biotechnologie | Vereinigte Staaten
$$
(Vom Mitglied beendet)